The benefits and efficacy of Accelerated Hydrogen Peroxide® have been recognized by peer reviewed clinical studies conducted by scientific organizations and third party researchers and labs in Canada, the U.S., Europe, and Asia.
AHP® has received approvals from Health Canada, US EPA (Environmental Protection Agency), US FDA (Food and Drug Administration), EU (European Union), New Zealand, Australia and 40 other countries. AHP® has been the subject of more than 45 favourably written peer reviewed scientific studies. After rigorous due diligence, Virox’s Global Strategic Alliance Partners, who serve many industries, selected AHP® as their infection prevention platform, which is a testament to the strength of the intellectual property and sustainability of the technology.
